Multicenter AIDS Cohort Study (MACS), Limited Competition (U01)

The summary for the Multicenter AIDS Cohort Study (MACS), Limited Competition (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Multicenter AIDS Cohort Study (MACS), Limited Competition (U01): -Purpose. This limited competition Funding Opportunity Announcement (FOA) solicits applications to continue projects currently funded at the five sites of the Multicenter AIDS Cohort Study (MACS) for a 5-year period as early as April 1, 2009. The MACS is a multi-site prospective epidemiology cohort study of men who have sex with men who are either infected with HIV or at increased risk for such infection. The MACS cohort was established in 1983 and has participated in follow-up visits at six-month intervals since that time. The study is currently funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute (NCI). Due to the unique characteristics of the study population, longitudinal data and specimens collected, and the need for continuing follow-up, competition will be restricted to the five current MACS institutions. -The specific objective and scope for continuing the MACS is to address research questions on the natural and treated history of HIV infection in a representative cohort of homosexual/bisexual men in the United States as well as emerging questions concerning HIV infection and treatment. The MACS, by prospectively studying a cohort of homosexual/bisexual men with or at high risk for HIV infection, is providing detailed information relevant to the evolving biological and psychosocial characteristics of the HIV/AIDS epidemic in the U.S. as well as the effects of long-term HIV infection and treatment.